Voglistar -MD 0.3 Tablet
By Voglistar
Rx
10 Tablet MD in a Strip

Composition
Voglibose(0.3mg)

Manufacturer - Mankind Pharma Ltd
208, Okhla Industrial Estate, Phase III, New Delhi - 110020

Expires on or after
February, 2026
About Voglistar -MD 0.3 Tablet
Voglistar -MD 0.3 Tablet is a medication specifically designed to manage type 2 diabetes mellitus, a chronic condition where the body struggles with insulin production or utilization. This tablet is crucial in regulating high blood sugar levels post-meal, especially when other medications and a controlled diet have not been effective. It is essential to take this tablet just before a meal as directed by your doctor to ensure proper blood sugar control.
While using Voglistar -MD 0.3 Tablet, it is advised to incorporate a holistic treatment approach, which includes maintaining a healthy diet, engaging in regular exercise, and following weight reduction recommendations from your healthcare provider. Regular monitoring of blood sugar levels is also necessary during the treatment course to gauge its effectiveness.
It is crucial not to discontinue taking Voglistar -MD 0.3 Tablet abruptly without consulting your doctor, as this can lead to a sudden spike in blood sugar levels, potentially resulting in severe complications like kidney damage and vision problems. If you encounter side effects such as flatulence, stomach pain, loss of appetite, constipation, or diarrhea, it is advisable to consult your doctor promptly.
Notably, Voglistar -MD 0.3 Tablet, which contains Voglibose, falls under the category of Anti-diabetic medications and can significantly improve post-meal blood glucose levels when used in conjunction with a proper diet and exercise routine. It is especially beneficial when standard treatments alone have not achieved the desired glycemic control.
However, certain precautions should be taken into consideration before using Voglistar -MD 0.3 Tablet. It is not recommended for individuals experiencing severe ketosis, diabetic coma, or pre-coma, as well as those with severe infections, post-surgery situations, severe trauma, or gastrointestinal obstructions. Moreover, pregnant or breastfeeding women, children, and adolescents should avoid using this medication.
Patients with specific medical conditions such as gallstone ileus, Roemheld’s syndrome, stenosis, liver or kidney issues, and elderly individuals need to exercise caution while using Voglistar -MD 0.3 Tablet. Common side effects may include soft stools or diarrhea, flatulence, bloating, abdominal discomfort, fullness, and nausea. If any of these symptoms worsen, seeking advice from your doctor is recommended.
Benefits
Voglistar -MD 0.3 Tablet offers several important benefits in the treatment of Type 2 diabetes mellitus. This medication plays a crucial role in controlling high blood glucose levels, which is essential for managing diabetes effectively. By slowing down the process of breaking down food in the intestine into simple glucose, Voglistar -MD 0.3 Tablet helps to prevent rapid spikes in blood sugar levels after meals. Maintaining lower blood glucose levels is vital as it reduces the risk of developing severe complications associated with diabetes, such as kidney damage, eye problems, nerve issues, and even possible limb amputations.
For individuals with type 2 diabetes and existing cardiovascular disease, Voglistar -MD 0.3 Tablet also offers a significant advantage by reducing the risk of mortality from cardiovascular issues. This medication, when taken regularly as prescribed, in combination with a proper diet and exercise regimen, can greatly contribute to a healthier and more stable life. It is crucial to adhere to the recommended usage of Voglistar -MD 0.3 Tablet to safeguard future health and continue to benefit from its protective effects.
In conclusion, Voglistar -MD 0.3 Tablet presents a comprehensive approach to managing Type 2 diabetes mellitus by controlling blood glucose levels effectively, reducing the risk of serious complications, and enhancing overall cardiovascular health. By incorporating this medication into your daily routine as directed, you can work towards living a normal and healthy life while safeguarding your future well-being.
How to use the Voglistar -MD 0.3 Tablet
To use Voglistar -MD 0.3 Tablet, follow the dosage and duration recommended by your doctor. It is important not to handle the tablets with wet hands to avoid any damage. Place the tablet in your mouth, but do not swallow it. Remember to take Voglistar -MD 0.3 Tablet on an empty stomach for best results. Taking the medication according to your doctor's instructions is crucial for its effectiveness.
Uses of Voglistar -MD 0.3 Tablet
Voglistar -MD 0.3 Tablet is primarily used to treat Type 2 diabetes mellitus. Type 2 diabetes is a common condition that affects how the body processes blood sugar (glucose). By taking Voglistar -MD 0.3 Tablet as prescribed, it helps to regulate blood sugar levels in individuals with Type 2 diabetes. This medication is an important part of the overall treatment plan for managing diabetes, alongside a healthy diet and regular exercise. Always follow your healthcare provider's instructions on how to use Voglistar -MD 0.3 Tablet for the best results in managing Type 2 diabetes mellitus.
What conditions Voglistar -MD 0.3 Tablet treats?
Voglistar -MD 0.3 Tablet is used in the treatment of Type 2 diabetes mellitus. It works by controlling high blood sugar levels, particularly after meals. Lowering blood sugar is crucial in managing diabetes and reducing the risk of complications like kidney damage, eye damage, nerve issues, and limb loss. This medication is beneficial for those with type 2 diabetes and existing cardiovascular disease, as it reduces the risk of fatality from cardiovascular issues. When used consistently with a proper diet and exercise regimen, Voglistar -MD 0.3 Tablet supports a healthy, normal life.
Should you consult a doctor?
Seek medical attention if you experience persistent side effects such as skin rash, flatulence, abdominal pain, or diarrhea while taking Voglistar -MD 0.3 Tablet. Additionally, consult your doctor if you have kidney or liver problems, or if you have ulceration or inflammation in the bowel. Pregnant or breastfeeding women should also seek medical advice before using this medication. If you notice any unusual symptoms or if your blood sugar levels are not adequately controlled, consult your doctor promptly. Do not hesitate to seek medical assistance if you feel unwell or if you are concerned about your health while taking Voglistar -MD 0.3 Tablet. Your doctor will be able to assess your condition and provide appropriate guidance tailored to your specific needs.
Side effects of Voglistar -MD 0.3 Tablet
When taking Voglistar -MD 0.3 Tablet, you may experience some side effects, although most of them do not need medical attention and tend to improve as your body gets used to the medication. However, if these side effects persist or if you are concerned about them, it is important to consult your doctor. Some common side effects that have been reported include skin rash, flatulence, abdominal pain, and diarrhea. If you notice any of these side effects while taking Voglistar -MD 0.3 Tablet, please consult your healthcare provider for further guidance and support.
Safety advice

liver
Caution When using Voglistar -MD 0.3 Tablet, it is important to be cautious if you have severe liver disease. In such cases, your doctor may recommend adjusting the dosage of Voglistar -MD 0.3 Tablet to ensure your safety. It is advisable to consult your doctor for proper guidance regarding the use of this medication in relation to liver issues.

kidney
Voglistar -MD 0.3 Tablet needs caution in severe kidney disease. Consult doctor for possible dose adjustment.

alcohol
It is not safe to drink alcohol while taking Voglistar -MD 0.3 Tablet. It's important to avoid alcohol to prevent any negative effects.

driving
Voglistar -MD 0.3 Tablet typically does not impact your driving ability.

pregnancy
Voglistar -MD 0.3 Tablet is generally safe to use during pregnancy. Animal studies show minimal adverse effects on the developing baby, but there is limited human data available.

breastfeeding
During breastfeeding, Voglistar -MD 0.3 Tablet is likely safe to use based on limited human data indicating low risk to the baby.
Consumption warning before consuming Voglistar -MD 0.3 Tablet
Before consuming Voglistar -MD 0.3 Tablet, there are important precautions to be aware of. This medication is specifically used for treating type 2 diabetes mellitus by controlling high blood sugar levels post-meal when other treatments and dietary restrictions have been ineffective. It should be taken before a meal as directed by your doctor to ensure proper blood sugar level management. Abruptly stopping the medication can lead to a dangerous increase in blood sugar levels, possibly resulting in severe complications such as kidney damage and vision problems.
Voglistar -MD 0.3 Tablet is only a part of an overall treatment plan that includes a balanced diet, regular exercise, and weight control as prescribed by your doctor. While taking this medication, regularly monitor your blood sugar levels to ensure efficacy and safety. Common side effects may include gas, stomach discomfort, appetite changes, constipation, and diarrhea. If these symptoms persist or become bothersome, consult your doctor promptly.
It's crucial to note that Voglistar -MD 0.3 Tablet alone does not cause low blood sugar levels, but when combined with certain other diabetes medications, it can lead to hypoglycemia. In case of hypoglycemia, prompt treatment with glucose is necessary. Before starting this medication, inform your doctor about any existing kidney or liver issues, bowel inflammation, or ulcers. Pregnant or nursing women should seek medical advice before usage, and disclosing all current medications is essential to avoid potential interactions. Additionally, excessive alcohol consumption while on this medication can increase the risk of low blood sugar levels.
What if you forgot to take Voglistar -MD 0.3 Tablet?
If you happen to miss a dose of Voglistar -MD 0.3 Tablet, simply skip the missed dose and carry on taking it as scheduled. It's important not to take a double dose to make up for the missed one. Just continue with your usual dosing routine to maintain the effectiveness of the medication.
Related lab tests
Related Lab Tests for monitoring while taking Voglistar -MD 0.3 Tablet include Glucose - Fasting Blood, Glucose - Postprandial Blood, and Glycosylated Hemoglobin. These tests help in checking your blood sugar levels before and after eating, as well as provide an average of your blood sugar control over the past few months. Monitoring these levels is important for managing diabetes and ensuring the effectiveness of Voglistar -MD 0.3 Tablet in controlling blood sugar levels. Regularly performing these tests as recommended by your healthcare provider can help in evaluating the response to the medication and making necessary adjustments to your treatment plan.
Additional Information
Habit Forming | No |
Chemical Class | Valiolamine derivative |
Therapeutic Class | ANTI DIABETIC |
Action Class | Alpha-glucosidase inhibitors |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹109
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024